Cargando…

Eukaryotic initiation factor 4A2 promotes experimental metastasis and oxaliplatin resistance in colorectal cancer

BACKGROUND: Deregulation of protein translation control is a hallmark of cancers. Eukaryotic initiation factor 4A2 (EIF4A2) is required for mRNA binding to ribosome and plays an important role in translation initiation. However, little is known about its functions in colorectal cancer (CRC). METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zhan-Hong, Qi, Jing-Jing, Wu, Qi-Nian, Lu, Jia-Huan, Liu, Ze-Xian, Wang, Yun, Hu, Pei-Shan, Li, Ting, Lin, Jin-Fei, Wu, Xiang-Yuan, Miao, Lei, Zeng, Zhao-Lei, Xie, Dan, Ju, Huai-Qiang, Xu, Rui-Hua, Wang, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518650/ https://www.ncbi.nlm.nih.gov/pubmed/31088567 http://dx.doi.org/10.1186/s13046-019-1178-z

Ejemplares similares

Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis
por: Lin, Jin-Fei, et al.
Publicado: (2022)

LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer
por: Wang, Yun, et al.
Publicado: (2019)

Photodynamic therapy augments oxaliplatin-induced immunogenic cell death in colorectal cancer
por: Wang, Xiaobo, et al.
Publicado: (2023)

Oxaliplatin-incorporated micelles eliminate both cancer stem-like and bulk cell populations in colorectal cancer
por: Wang, Ke, et al.
Publicado: (2011)

METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway
por: Yang, Dong-Dong, et al.
Publicado: (2020)

VDR–SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironment
por: Hu, Pei-Shan, et al.
Publicado: (2020)

FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis
por: Ruan, Dan-Yun, et al.
Publicado: (2021)

The lncRNA XIST/miR‐125b‐2‐3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancer
por: Zeng, Zhao‐lei, et al.
Publicado: (2021)

Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation
por: Lu, Yun-Xin, et al.
Publicado: (2018)

Localized and triggered release of oxaliplatin for the treatment of colorectal liver metastasis
por: Gogineni, Venkateswara R, et al.
Publicado: (2020)

The Clinical and Biomarker Association of Programmed Death Ligand 1 and its Spatial Heterogeneous Expression in Colorectal Cancer
por: Wei, Xiao-Li, et al.
Publicado: (2018)

Oxaliplatin related lncRNAs prognostic models predict the prognosis of patients given oxaliplatin-based chemotherapy
por: Zhou, Qing-nan, et al.
Publicado: (2023)

Ursolic acid synergistically enhances the therapeutic effects of oxaliplatin in colorectal cancer
por: Shan, Jianzhen, et al.
Publicado: (2016)

Synergistic effect of sodium butyrate and oxaliplatin on colorectal cancer
por: Shuwen, Han, et al.
Publicado: (2022)

A two-microRNA-based signature predicts first-line chemotherapy outcomes in advanced colorectal cancer patients
por: Lu, Jia-huan, et al.
Publicado: (2018)

Overexpressed GATA3 enhances the sensitivity of colorectal cancer cells to oxaliplatin through regulating MiR-29b
por: Wang, Wei, et al.
Publicado: (2020)

Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis
por: Lu, Min, et al.
Publicado: (2017)

Adjuvant oxaliplatin-based chemotherapy effect after treatment of colorectal hepatic metastasis
por: Kang, Mee-Young, et al.
Publicado: (2021)

Nonhomologous end joining key factor XLF enhances both 5-florouracil and oxaliplatin resistance in colorectal cancer
por: Liu, Zhuo, et al.
Publicado: (2019)

Exosomes in metastasis of colorectal cancers: Friends or foes?
por: Wu, Zheng, et al.
Publicado: (2023)

Eukaryotic translation initiation factor 5A in the pathogenesis of cancers
por: Ning, Liang, et al.
Publicado: (2020)

Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of TGF-β/Smad2/3 signaling pathway
por: Yin, Jiahuan, et al.
Publicado: (2019)

The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer
por: Li, Jia-Jun, et al.
Publicado: (2023)

Screening of molecular targets and construction of a ceRNA network for oxaliplatin resistance in colorectal cancer
por: Wei, Wu, et al.
Publicado: (2019)

Modulation of Redox Homeostasis by Inhibition of MTHFD2 in Colorectal Cancer: Mechanisms and Therapeutic Implications
por: Ju, Huai-Qiang, et al.
Publicado: (2018)

Inhibition of the PLK1‐Coupled Cell Cycle Machinery Overcomes Resistance to Oxaliplatin in Colorectal Cancer
por: Yu, Zhaoliang, et al.
Publicado: (2021)

METTL3 facilitates tumor progression via an m(6)A-IGF2BP2-dependent mechanism in colorectal carcinoma
por: Li, Ting, et al.
Publicado: (2019)

Irinotecan- vs oxaliplatin-based regimens for neoadjuvant chemotherapy in colorectal liver metastasis patients: A retrospective study
por: Liu, Wei, et al.
Publicado: (2022)

CAMTA1–PPP3CA–NFATc4 multi-protein complex mediates the resistance of colorectal cancer to oxaliplatin
por: Pan, Ruijun, et al.
Publicado: (2022)

Nicotinamide nucleotide transhydrogenase-mediated redox homeostasis promotes tumor growth and metastasis in gastric cancer
por: Li, Shuai, et al.
Publicado: (2018)

Chemo-Immunotherapy with Oxaliplatin and Interleukin-7 Inhibits Colon Cancer Metastasis in Mice
por: Gou, Hong-Feng, et al.
Publicado: (2014)

Role of oxaliplatin in the treatment of colorectal cancer
por: Comella, Pasquale, et al.
Publicado: (2009)

Oxaliplatin-Induced Neuropathy in Colorectal Cancer
por: Weickhardt, Andrew, et al.
Publicado: (2011)

Targeting hexokinase 2 increases the sensitivity of oxaliplatin by Twist1 in colorectal cancer
por: Zhang, Bo, et al.
Publicado: (2021)

Analysis of the efficacy and safety of a combined gemcitabine, oxaliplatin and pegaspargase regimen for NK/T-cell lymphoma
por: Wang, Jing-hua, et al.
Publicado: (2016)

An in silico exploration of combining Interleukin-12 with Oxaliplatin to treat liver-metastatic colorectal cancer
por: Wang, Qing, et al.
Publicado: (2020)

The role of eukaryotic translation initiation factor 6 in tumors
por: Zhu, Wei, et al.
Publicado: (2017)

Oxaliplatin-induced peripheral neurotoxicity in colorectal cancer patients: mechanisms, pharmacokinetics and strategies
por: Cheng, Fang, et al.
Publicado: (2023)

Postoperative oxaliplatin-based hyperthermic intraperitoneal chemotherapy: an effective and safe palliative treatment option for colorectal cancer with peritoneal metastasis
por: Sun, Tuanhe, et al.
Publicado: (2021)

Eukaryotic initiation factor 3, subunit C silencing inhibits cell proliferation and promotes apoptosis in human ovarian cancer cells
por: Wen, Fang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5148sp7rh58bjgl8nnum720nor